![Li Zeng](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Li Zeng
Direktör/Styrelseledamot på
EXTRAWELL PHARMACEUTICAL HOLDINGS LIMITED
Profil
Li Zeng currently works at Extrawell Pharmaceutical Holdings Ltd., as Independent Non-Executive Director from 2024 and CytoCares Shanghai, Inc., as Chief Operating Officer.
Dr. Zeng received his undergraduate degree in 2000 from Fudan University and doctorate degree in 2005 from Fudan University.
Aktiva positioner av Li Zeng
| Företag | Position | Start |
|---|---|---|
| EXTRAWELL PHARMACEUTICAL HOLDINGS LIMITED | Direktör/Styrelseledamot | 2024-06-07 |
CytoCares Shanghai, Inc.
 CytoCares Shanghai, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative multispecific antibody drugs for oncology and autoimmune diseases | Verksamhetschef | - |
Li Zengs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
96
Första gradens relationer
3
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
Extrawell Pharmaceutical Holdings Ltd.
 Extrawell Pharmaceutical Holdings Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Fudan University
 Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytoCares Shanghai, Inc.
CytoCares Shanghai, Inc. Pharmaceuticals: MajorHealth Technology Develops innovative multispecific antibody drugs for oncology and autoimmune diseases | Health Technology |
